Two patients experienced DLTs in this study (cytokine release syndrome and ILD each), whereas three patients experienced DLTs in the US phase I study (deep venous thrombosis at 100 mg/m2, elevation of ALT/AST and serum sickness at 400 mg/m2). This evidence concerns the gene GPT and interstitial lung disease.